Neuromuscular Disorders
Volume 18, Issue 1 , Pages 90-96 , January 2008

147th ENMC International Workshop: Guideline on processing and evaluation of sural nerve biopsies, 15–17 December 2006, Naarden, The Netherlands

  • C. Sommer

      Affiliations

    • Department of Neurology, University of Würzburg, Würzburg, Josef-Schneider-Str. 11, 97080 Würzburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 931 201 23763; fax: +49 931 201 23697.
    • ,
  • S. Brandner

      Affiliations

    • Department of Neuropathology, Institute of Neurology, London, United Kingdom
    • ,
  • P.J. Dyck

      Affiliations

    • Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, United States
    • ,
  • L. Magy

      Affiliations

    • Department of Neurology, CHRU Dupuytren, Limoges, France
    • ,
  • S.I. Mellgren

      Affiliations

    • Department of Neurology, University of Tromsö, Tromsö, Norway
    • ,
  • M. Morbin

      Affiliations

    • IRCCS Foundation - Neurological Institute “Carlo Besta”, Milan, Italy
    • ,
  • A. Schenone

      Affiliations

    • Department of Neurosciences, Ophthalmology and Genetics, Universita degli Studi, Genova, Italy
    • ,
  • E. Tan

      Affiliations

    • Department of Neurology, Hacettepe University, Ankara, Turkey
    • ,
  • J. Weis

      Affiliations

    • Department of Neuropathology, University of Aachen, Aachen, Germany

Received 3 August 2007

References 

  1. Gabriel CM, Howard R, Kinsella N, Lucas S, McColl I, Saldanha G, et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry. 2000;69:442–446
  2. Deprez M, de Groote CC, Gollogly L, Reznik M, Martin JJ. Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul Disord. 2000;10:92–98
  3. Dyck PJ, Dyck PJB, Engelstad JN. Pathological alterations of nerves. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsevier Saunders; 2005. p. 733–29.
  4. Bosboom WM, Van den Berg LH, De Boer L, Van Son MJ, Veldman H, Franssen H, et al. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy. Neurology. 1999;53:837–845
  5. Eurelings M, van den Berg LH, Wokke JH, Franssen H, Vrancken AF, Notermans NC. Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy. Neurology. 2003;61:707–709
  6. Jann S, Bramerio MA, Beretta S, Koch S, Defanti CA, Toyka KV, et al. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP. Neurology. 2003;61:1607–1610
  7. Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology. 2005;65:1924–1929
  8. Dyck PJ, Johnson WJ, Lambert EH, O’Brien PC. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc. 1971;46:400–431
  9. Haq RU, Fries TJ, Pendlebury WW, Kenny MJ, Badger GJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol. 2000;57:1745–1750
  10. Bosboom WM, van den Berg LH, Franssen H, Giesbergen PC, Flach HZ, van Putten AM, et al. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain. 2001;124:2427–2438
  11. Dyck PJ, Thomas PK. Peripheral neuropathy. 4th ed.. Philadelphia: Elsevier; 2005;
  12. King R. Atlas of peripheral nerve pathology. London: Arnold; 1999;
  13. Schröder JM. Pathologie peripherer Nerven. Berlin: Springer-Verlag; 1999;
  14. Midroni G, Bilbao JM. Biopsy diagnosis of peripheral neuropathy. Boston: Butterworth-Heinemann; 1995;
  15. Vital C, Vallat JM. Ultrastructural study of the human diseased peripheral nerve. New York: Elsevier; 1987;
  16. Stendel C, Roos A, Deconinck T, Pereira J, Castagner F, Niemann A, et al. Peripheral nerve demyelination caused by a mutant rho GTPase guanine nucleotide exchange factor, Frabin/FGD4. Am J Hum Genet. 2007;81:158–164
  17. Yeung KB, Thomas PK, King RH, Waddy H, Will RG, Hughes RA, et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol. 1991;238:383–391
  18. Ritz MF, Erne B, Ferracin F, Vital A, Vital C, Steck AJ. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening. Muscle Nerve. 1999;22:1030–1037
  19. Gabriel JM, Erne B, Bernasconi L, Tosi C, Probst A, Landmann L, et al. Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol (Berl). 1998;95:540–546
  20. Eurelings M, Moons KG, Notermans NC, Sasker LD, De Jager AE, Wintzen AR, et al. Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide. Neurology. 2001;56:228–233
  21. Satoi H, Oka N, Kawasaki T, Miyamoto K, Akiguchi I, Kimura J. Mechanisms of tissue injury in vasculitic neuropathies. Neurology. 1998;50:492–496
  22. Kieseier BC, Clements JM, Pischel HB, Wells GM, Miller K, Gearing AJ, et al. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome. Ann Neurol. 1998;43:427–434
  23. Leppert D, Hughes P, Huber S, Erne B, Grygar C, Said G, et al. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology. 1999;53:62–70
  24. Kurz M, Pischel H, Hartung HP, Kieseier BC. Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system. J Peripher Nerv Syst. 2005;10:311–318
  25. Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJ. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci. 2001;21:7576–7586
  26. Haslbeck KM, Bierhaus A, Erwin S, Kirchner A, Nawroth P, Schlotzer U, et al. Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy. Muscle Nerve. 2004;29:853–860
  27. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest. 2004;114:1741–1751
  28. Andorfer B, Kieseier BC, Mathey E, Armati P, Pollard J, Oka N, et al. Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol. 2001;116:226–232
  29. Mazzeo A, Aguennouz M, Messina C, Vita G. Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy. Arch Neurol. 2004;61:1097–1102
  30. Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, et al. Management of paraneoplastic neurological syndromes: report of an EFNS task force. Eur J Neurol. 2006;13:682–690
  31. Vallat JM, De MH, Bordessoule D, Jauberteau MO, Tabaraud F, Gelot A, et al. Non-Hodgkin malignant lymphomas and peripheral neuropathies – 13 cases. Brain. 1995;118:1233–1245

PII: S0960-8966(07)00721-3

doi: 10.1016/j.nmd.2007.08.010

Neuromuscular Disorders
Volume 18, Issue 1 , Pages 90-96 , January 2008

Article Tools